This conclusion was further supported by our in vivo findings using the xenograft and renal capsule tumors established in nude mice that HSP90 or Src antagonism alone was sufficient to suppress HCT116/R cells’ primary tumor growth, hematogenous spread, and distal metastatic potential. This evidence concerns the gene SRC and neoplasm.